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RESEARCH ARTICLE
EFN-4 functions in LAD-2-mediated axon guidance in
Caenorhabditis elegans
Bingyun Dong1, Melinda Moseley-Alldredge1,2, Alicia A. Schwieterman3, Cory J. Donelson3,*,
Jonathan L. McMurry3, Martin L. Hudson3 and Lihsia Chen1,2,‡
ABSTRACT
During development of the nervous system, growing axons rely on
guidance molecules to direct axon pathfinding. A well-characterized
family of guidance molecules are the membrane-associated ephrins,
which together with their cognate Eph receptors, direct axon navigation
in a contact-mediated fashion. In C. elegans, the ephrin-Eph signaling
system is conserved and is best characterized for their roles in
neuroblast migration during early embryogenesis. This study
demonstrates a role for the C. elegans ephrin EFN-4 in axon
guidance. We provide both genetic and biochemical evidence that is
consistent with the C. elegans divergent L1 cell adhesion molecule
LAD-2 acting as a non-canonical ephrin receptor to EFN-4 to promote
axon guidance. We also show that EFN-4 probably functions as a
diffusible factor because EFN-4 engineered to be soluble can promote
LAD-2-mediated axon guidance. This study thus reveals a potential
additional mechanism for ephrins in regulating axon guidance and
expands the repertoire of receptors by which ephrins can signal.
KEY WORDS: C. elegans, Ephrin, L1CAM, Axon guidance
INTRODUCTION
Neural circuitries underlying complex behaviors require precise
neuronal connections that are formed during development. The
specificity of these connections requires accurate axon pathfinding,
which is controlled by many molecules, including growth factors,
adhesion molecules, and long- and short-range guidance cues and
their receptors. An important class of guidance cues are the ephrins,
which are either glycosyl-phosphatidylinositol (GPI) linked or
single-pass transmembrane proteins (Helmbacher et al., 2000; Luria
et al., 2008; Wang et al., 2001). In mammals, the five GPI-linked
‘A’ class ephrins and the three transmembrane ‘B’ class ephrins act
as short-range guidance cues that signal via their cognate A or B
class Eph receptor tyrosine kinases. Classically, ephrins signal by
forming trans interactions with Eph receptors on opposing tissues.
These interactions generally result in repulsion when the associated
ephrins are proteolytically released by ADAM (A disintegrin and
metalloprotease) proteins (Egea and Klein, 2007; Hattori et al.,
2000; Janes et al., 2005). The level of repulsion or adhesion between
the two opposing tissues can be modulated by a variety of
mechanisms, including cis interactions between ephrin and the Eph
receptor (Hornberger et al., 1999; Kao and Kania, 2011).
Ephrins and Eph receptors are also conserved inC. elegans, whose
genome contains four genes (efn-1 to efn-4) that encode GPI-linked
ephrins and a single gene (vab-1) that encodes an Eph receptor (Chin-
Sang et al., 1999, 2002; George et al., 1998; Wang et al., 1999).
Although a role in axon guidance has been demonstrated for the
VAB-1/Eph receptor (Boulin et al., 2006; Mohamed and Chin-Sang,
2006) and the EFN-1 ephrin (Grossman et al., 2013), the C. elegans
ephrins and VAB-1 have been best characterized for their role in
embryonic morphogenesis. EFN-1, EFN-2 and EFN-3 function
together in epidermal cell organization, signaling through VAB-1
(Chin-Sang et al., 1999; Wang et al., 1999). Although EFN-4 also
functions in epidermal morphogenesis, its role appears to be
predominantly independent of VAB-1. Indeed, epidermal
morphogenesis defects in efn-4 null embryos are synergistically
enhanced in a vab-1 null background, consistent with each protein
functioning in parallel pathways (Chin-Sang et al., 2002). EFN-4 also
plays a major role in morphogenesis of the male tail, a process in
which VAB-1 and the other three ephrins have not been reported to
participate (Ikegami et al., 2004; Nakao et al., 2007). More recently,
EFN-4was revealed to have a role in promoting axon branching that is
also partially independent of VAB-1 (Schwieterman et al., 2016).
These studies collectively suggest the presence of additional receptors
for ephrins besides the Eph receptors.
Here, we present genetic evidence showing that EFN-4 plays a
role in axon guidance, probably by acting as a soluble factor. We
provide both genetic and biochemical data that is consistent with
LAD-2, a non-canonical L1 cell adhesion molecule, acting as an
EFN-4 receptor.
RESULTS
efn-4 functions in the same genetic pathwayas lad-2 in axon
guidance
Prior studies established EFN-4 and MAB-20/semaphorin as
essential for male tail morphogenesis (Ikegami et al., 2004;
Nakao et al., 2007). In these studies, EFN-4 and MAB-20 are
shown to function in common pathways. Although MAB-20
signaling is mediated by the PLX-2 plexin receptor, it is not clear
how the EFN-4 signal is communicated. In another genetic study,
both EFN-4 and MAB-20 are shown to function together in
embryonic epidermal morphogenesis (Chin-Sang et al., 2002). We
previously showed that MAB-20 functions to direct axon
pathfinding of the SDQL, SDQR, SMD and PLN neurons; MAB-
20 signal is mediated via the PLX-2/plexin receptor and LAD-2, a
non-canonical L1 cell adhesion molecule (L1CAM) that functions
as a MAB-20 co-receptor and is expressed in these neurons (Wang
et al., 2008). Given that EFN-4 and MAB-20 function in common
processes and the fact that efn-4 is expressed in the nervous system,
including several lateral and tail neurons (Chin-Sang et al., 2002;
also see Fig. S1), we tested the possibility that EFN-4 might
also direct pathfinding of axons that rely on MAB-20, PLX-2 andReceived 23 July 2015; Accepted 12 February 2016
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LAD-2. Using a lad-2 transcriptional GFP reporter, we examined
the axon trajectories of the SDQL, SDQR, SMD and PLN neurons
in efn-4 null animals and observed significant abnormalities
(Fig. 1). In particular, the SDQL axon exhibited two phenotypes
that were strikingly similar to those observed in lad-2 null animals
(Fig. 1Aii-Av). In wild-type animals, the SDQL neuron extended a
single dorsal axon (Fig. 1Ai, double-headed arrow) that joins the
lateral nerve cord, along which it migrates anteriorly before making
a second dorsal turn (Fig. 1Ai, arrow) to join the sublateral nerve
cord, along which it continues to migrate anteriorly towards the
nerve ring. In 37% of efn-4 null animals, the SDQL axon failed to
make the second dorsal turn, migrating ventrally instead (Fig. 1Aiv,
arrow). The efn-4 SDQL neuron also often extended an additional
axon from the cell body that typically migrates in the opposite
direction to the primary axon (Fig. 1Av). These shared axon defects
in efn-4 and lad-2 null animals suggest that both genes function in
the same genetic pathway. Consistent with this hypothesis, the
observed SDQL, SDQR, SMD and PLN axon defects in efn-4; lad-
2 double mutant animals are no worse than those observed in lad-2
single mutant animals (Fig. 1B).
To evaluate whether VAB-1, the sole C. elegans Eph receptor,
participates with EFN-4 in guiding axon migration, we first
examined vab-1 null animals for similar defects in the
aforementioned sublateral axons. Although the penetrance of PLN
axon defects in vab-1 null animals is similar to efn-4 null animals,
we observed a more modest level of SMD, SDQL and SDQR axon
guidance defects in vab-1 null animals compared with efn-4 null
animals (Fig. 1B). These results reveal a pathfinding role for vab-1
in these sublateral axons. Owing to synthetic embryonic lethality in
vab-1; efn-4mutant backgrounds (Chin-Sang et al., 2002), we were
unable to evaluate whether efn-4 and vab-1 function in the same
pathway. But the more penetrant SDQL, SDQR and SMD axon
defects in efn-4 animals suggest that EFN-4 can function, at least
partially, independent of VAB-1.
Fig. 1. efn-4 animals exhibit abnormal axon trajectories in lad-
2-expressing neurons. (A) Confocal micrographs of the SDQL
neuron (arrowhead) in adult wild-type, lad-2 and efn-4 animals
expressing Plad-2::gfp; left lateral view. The wild-type SDQL
neuron (Ai) extends a single dorsal axon (double-headed arrow)
that migrates anteriorly before making a dorsal turn (arrow) and
navigating anteriorly again. The SDQL axon in efn-4(bx80) animals
exhibit strikingly similar abnormalities to those observed in lad-2
(tm3056) animals. Instead of a second dorsal migration, the SDQL
axon often navigates ventrally (arrow) in lad-2 (Aii) and efn-4
animals (Aiv). The SDQL neuron sometimes displays a bipolar
phenotype, extending a second axon that migrates ventrally
(arrow) in lad-2 (Aiii) and efn-4 animals (Av). (B) Quantitation of
abnormal axon pathfinding (Bi) observed in SDQL as well as
additional lad-2-expressing neurons, SDQR, SMD and PLN and
(Bii) bipolar phenotype in SDQL. Error bars indicate standard error
of proportion of three sample sets, where n=100 animals for each
set. *P<0.05, ***P<0.0005. n.s., not significant.
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To determine how vab-1 functions relative to lad-2, we examined
axon defects in vab-1; lad-2 animals. PLN defects in vab-1; lad-2
animals showed increased penetrance (Fig. 1B) that is consistent
with additive effects, suggesting that vab-1 and lad-2 function in
distinct pathways in PLN pathfinding. However, SDQL, SDQR and
SMD axon defects in vab-1; lad-2 animals showed either some
reduction or no significant difference in penetrance compared with
that in lad-2 animals, consistent with both genes having antagonistic
roles or sharing a common pathway.
efn-4 functions in adistinct pathway frommab-20andplx-2 in
LAD-2-mediated axon guidance
As the SDQL defects in both efn-4 and lad-2 null mutants are
strikingly similar, we focused on the SDQLneuron as amodel system
to dissect how efn-4mediates in axon guidance. To assess how efn-4
functions relative tomab-20 and plx-2, we compared SDQL axons in
each singlemutant strain relative tomab-20; plx-2,mab-20; efn-4 and
plx-2; efn-4 animals (Fig. 2). In agreement with mab-20 and plx-2
functioning in the same pathway (Ikegami et al., 2004; Nakao et al.,
2007; Wang et al., 2008), mab-20; plx-2 animals exhibited similar
levels of SDQL axon defects as mab-20 and plx-2 single mutant
animals (Fig. 2 andWang et al., 2008). By contrast, the penetrance of
SDQL defects in mab-20; efn-4 and plx-2; efn-4 animals were
increased overmab-2, plx-2 or efn-4 null animals, consistent with efn-
4 functioning in a distinct pathway from mab-20 and plx-2. In
analyzing how all three genes function relative to lad-2, our genetic
data indicate that loss of mab-20, plx-2 or efn-4 function does not
enhance SDQL axon defects in lad-2 animals (Fig. 2), thus revealing
that each of the three genes functions in the same pathway as lad-2.
LAD-2 biochemically interacts with EFN-4
Our genetic results suggest the presence of at least two distinct
pathways – mab-20 and efn-4 – that converge on LAD-2 to promote
SDQL axon guidance. Because LAD-2 is an established co-receptor
for the MAB-20 guidance cue (Wang et al., 2008), we hypothesized
that LAD-2 might also act as a receptor for EFN-4 and thus should
physically interact with EFN-4. To evaluate this possibility, we
performed co-immunoprecipitation (co-IP) assays on lysates of
HEK293T cells co-transfected with FLAG::EFN-4 and LAD-2::
HA. We detected LAD-2::HA in anti-FLAG immunoprecipitates as
determined by western blot analysis using anti-HA antibodies
(Fig. 3A). By contrast, no LAD-2::HA was detected in anti-FLAG
immunoprecipitates performed on cells co-transfected with LAD-2::
HA and control FLAG vector or with FLAG::EFN-4 and control HA
vector. These results indicate that LAD-2 and EFN-4 can
biochemically interact.
To assess the specificity of this biochemical interaction, we
performed co-IP assays assessing the ability of EFN-4 to interact
with MAB-20 and two immunoglobulin superfamily cell adhesion
molecules (IgCAMs): RIG-3, which also has axon guidance roles
(Schwarz et al., 2009) and SAX-7, the canonical C. elegans
L1CAM (Sasakura et al., 2005; Wang et al., 2005). These co-IP
assays failed to reveal an EFN-4 interaction with either MAB-20 or
RIG-3, confirming the specificity of the interaction between EFN-4
and LAD-2 (Fig. S2A) and agreeing with our genetic result that
Fig. 2. Genetic analysis reveals that efn-4 andmab-20 function in distinct
pathways. Quantitation of abnormal SDQL axon guidance observed in efn-4,
mab-20, plx-2 and lad-2 single and double mutant strains. Error bars indicate
standard error of proportion of three sample sets, where n=100 animals for
each set. ****P<0.0001.
Fig. 3. LAD-2 can biochemically interact with EFN-4 as determined by co-
immunoprecipitation assays and biolayer interferometry. (A) A western
blot showing results of a co-immunoprecipitation assay performed on lysates of
HEK293T cell expressing HA-tagged LAD-2 (LAD-2::HA) and/or FLAG-tagged
EFN-4 (FLAG::EFN-4). M.W., molecular weight markers. (B) BioLayer
Interferometry (BLI) reveals a fast-on, slow-off binding interaction between
LAD-2-AP and EFN-4-Fc. A BLI probe against human Fc was used to capture
secreted EFN-4-Fc in parallel with a secreted Fc control. After baseline
measurements in Opti-MEM medium alone, the captured EFN-4 ligand was
dipped into tissue culture supernatant from cells transiently transfected with a
secreted LAD-2-APexpression plasmid during the association phase (Bi), then
dipped into Opti-MEM during the dissociation phase (Bii). BLI measurements
of the Fc control interaction with LAD-2-AP showed no appreciable binding and
were used to correct for instrument drift. The negligible dissociation observed
in Bii is consistent with a high-affinity interaction between EFN-4 and LAD-2.
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efn-4 and mab-20 function in distinct genetic pathways. However,
the co-IP assays identified an interaction between EFN-4 and SAX-
7 – a result that is not surprising because SAX-7 and LAD-2 share a
highly conserved extracellular domain (Chen and Zhou, 2010;
Wang et al., 2008).
To further evaluate the binding of EFN-4 to LAD-2, we used
biolayer interferometry (BLI), an optical biosensing technique
similar to surface plasmon resonance that can measure the
association and disassociation of biomolecules (Abdiche et al.,
2008; Wartchow et al., 2011; Wilson et al., 2010). In BLI assays, we
immobilized EFN-4::Fc or the Fc control onto an anti-human Fc
capture probe, after which we immersed the probe into conditioned
tissue culture medium isolated from HEK293T cells transiently
expressing the LAD-2 extracellular domain fused to alkaline
phosphatase (LAD-2::AP). The BLI measurements collected over
a span of >3000 s are indicative of an association between LAD-2::
AP and EFN-4::Fc (Fig. 3B). By contrast, the Fc control showed
no significant association. To qualitatively evaluate the strength of
the LAD-2ECD::AP association with EFN-4::Fc, the probe
was subsequently immersed in naive tissue culture medium. BLI
measurements taken for >3000 s revealed little protein dissociation,
indicative of a strong affinity between LAD-2::AP and EFN-4.
These BLI analyses confirm that EFN-4 and LAD-2 can directly
bind each other. BLI measurements were also performed to assess
the interaction of RIG-3ECD::AP with EFN-4::Fc; no significant
interaction between EFN-4 and RIG-3 was found (Fig. S2B), in
agreement with our co-IP results.
EFN-4 can function non-cell autonomously to mediate axon
guidance
Ephrins can form cis or trans interactions with their cognate
Eph receptors to modulate contact-dependent axon migration
(Hornberger et al., 1999; Kao and Kania, 2011; Rashid et al.,
2005). As a GPI-linked molecule, EFN-4 could function in cis with
LAD-2 during SDQL axon migration or in trans, presented from
adjacent tissues. Throughout its entire navigation, the SDQL axon
extends along the hyp7 epidermal cell and is adjacent to the dorsal
body-wall muscles, which form the dorsal boundary that the axon
does not trespass beyond (Fig. 4A; White et al., 1986). On the basis
of EFN-4::GFP expression from the juIs109 transgene (Chin-Sang
et al., 2002), it was not clear whether EFN-4 is expressed in SDQL
neurons (Fig. S1). To determine whether EFN-4 is required in the
SDQL neuron, we tested for EFN-4 expression driven by the lad-2
promoter to rescue SDQL cell defects in efn-4 null animals. We
observed significant rescue of SDQL pathfinding (Fig. 4B),
consistent with a cell-autonomous role for EFN-4. To test whether
EFN-4 in adjacent tissues is also required for SDQL axon
pathfinding, we expressed EFN-4 in either hyp7 cells or body-
wall muscles under the control of the dpy-7 or myo-3 promoter,
respectively. Both promoters drive gene expression in the respective
tissues in embryos, larvae and adults (Fire and Waterston, 1989;
Gilleard et al., 1997; Okkema et al., 1993), thus EFN-4 would be
present when the SDQL axon initiates extension. We observed
significant SDQL cell rescue with EFN-4 expression in either hyp7
cells or body-wall muscles (Fig. 4B), demonstrating that EFN-4 can
act both cell autonomously and non-cell autonomously and that
EFN-4 expression in any of these tissues is sufficient to direct
SDQL axon pathfinding.
To further probe the non-cell autonomous action of EFN-4, we
assessed whether EFN-4 expression in remote cells, such as the RID
and touch receptor mechanosensory neurons (Fig. 5A), could
influence SDQL axon pathfinding. We used the mir-48 (Li et al.,
2005; Wang et al., 2008) and mec-7 promoters (Kim et al., 1999) to
express sustained levels of EFN-4 in the RID and touch receptor
mechanosensory neurons. RID is an embryonically derived neuron
whose axon is located in the dorsal nerve cord whereas axons of the
mechanosensory neurons, particularly PLM and PVM, are ventral
to the SDQL cell body and axon. Importantly, the axons of these
neurons are fully extended and already express EFN-4 by the time
the SDQL neuron initiates axon extension (White et al., 1986).
EFN-4 expression in either RID or the mechanosensory neurons
also rescues efn-4 SDQL cell defects (Fig. 5B), revealing that EFN-
4 expression in a distant tissue can direct SDQL axon guidance.
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Fig. 4. efn-4 can function non-cell autonomously to regulate SDQL axon
guidance. (A) Schematic of aC. elegansmid-body cross section, showing the
SDQL cell bodyand axon relative to other tissues. The SDQL neuron extends a
single dorsal axon from its cell body, migrating anteriorly before making a
dorsal turn until the axon reaches the left dorsal body-wall muscle, at which
point it migrates anteriorly. VNC, ventral nerve cord; DNC, dorsal nerve cord.
(B) Percentage of animals showing abnormal SDQL trajectories in different
genetic backgrounds and in efn-4(bx80) transgenic animals expressing efn-4
in different tissues with the use of tissue-specific promoters. In analyzing the
effects of each tissue-specific efn-4 expression on SDQL axon migration, we
examined three independent transgenic lines. Error bars indicate standard
error of proportion of three sample sets, where n=100 animals for each set.
*P<0.05, **P<0.01; n.s., not significant.
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EFN-4ΔGPI is sufficient to rescue SDQL axon guidance
defects
The ability for EFN-4, a membrane-associated protein, to impact
SDQL axon pathfinding when expressed in remote tissues is
puzzling. One possible explanation is that EFN-4 functions as a
diffusible molecule. To address this, we tested for the ability of a
non-membrane-associated form of EFN-4, which lacks the GPI-
modification signal sequence (EFN-4ΔGPI), to rescue SDQL axon
defects in efn-4 null animals. Indeed, SDQL defects were rescued
with expression of EFN-4ΔGPI, which is comparable with results
seen with full-length EFN-4 (Fig. 5B). Strikingly, we also
observed significant rescue with EFN-4ΔGPI expressed in the
more distant RID and touch receptor mechanosensory neurons
(Fig. 5B). Importantly, RID neuron expression of either GPI-
linked or EFN-4ΔGPI does not induce ectopic SDQL axon
guidance defects in wild-type animals (Fig. 5B). These results
suggest that membrane association is not necessary for EFN-4 to
mediate axon guidance.
Fig. 5. Membraneassociation ofEFN-4 is not required forEFN-4-mediated SDQLaxon guidance. (A) A schematic showing SDQL axon trajectory (red) relative to
thoseof theRID (pink) and severalmechanosensory (blue) neurons. (B)Quantitation of SDQLneurondefects inefn-4(bx80) andwild-typeanimalsexpressingEFN-4or
EFN-4ΔGPI in SDQL, RID and mechanosensory neurons. We examined three independent transgenic lines to analyze the effects of expression of each EFN-4 in
specific tissuesonSDQLmigration.Error bars indicatestandarderrorof proportionof threesamplesets,wheren=100animals foreachset. ***P<0.005; *P<0.05;n.s., not
significant. (C) Confocal micrographs showing EFN-4 immunolocalization in efn-4 null animals expressing full-length EFN-4 (Ci, Ciii) or EFN-4ΔGPI (Cii, Civ). Maximum
intensity z-series projections, revealing EFN-4 (Ci) and EFN-4ΔGPI (Cii) expression in lad-2-expressing neurons adjacent to the nerve ring (arrow); arrowhead indicates
axonal localization of EFN-4.EFN-4ΔGPI immunostaining (Cii) appears qualitativelyweaker than for full-lengthEFN-4 (Ci). Thisdifference ismore obviouswhenviewing
a single slice of the z series in Ciii and Civ. Arrows indicate EFN-4 localization in individual neurons. Scale bars: 20 µm. (D) Awestern blot showing results of an
immunoprecipitationassayperformedonsupernatant culturemedium(S)orcell lysates (C) ofHEK293Tcell expressingFLAG::EFN-4ΔGPIusingeitheranti-FLAG (F)or
anti-EFN-4 (E) antibodies. The immunoprecipitates were then examined by western blot analysis and probed with anti-FLAG antibodies to visualize the presence of
FLAG::EFN-4ΔGPI, marked with an arrow.
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The ability for remote EFN-4ΔGPI expression to rescue efn-4
SDQL axon guidance defects suggests that EFN-4ΔGPI is
diffusible. To test this hypothesis, we compared the localization
of EFN-4ΔGPI and EFN-4 in lad-2-expressing neurons of efn-4
transgenic animals via whole-animal immunostaining with
antibodies against EFN-4 (Chin-Sang et al., 2002). If EFN-4ΔGPI
is not membrane associated and is, in fact, secreted, then we predict
that EFN-4ΔGPI immunostaining might be less intense than that of
full-length EFN-4 and EFN-4ΔGPI accumulation might be detected
outside source cells. Although we did not detect EFN-4ΔGPI
accumulation outside lad-2-expressing neurons, EFN-4ΔGPI
immunodetection in lad-2-expressing neurons appeared
qualitatively weaker than for full-length EFN-4 (Fig. 5C),
consistent with our prediction. One alternative explanation for
the weaker signal is that EFN-4ΔGPI is not properly trafficked or
folded, thus resulting in protein degradation. In some GPI-linked
proteins, loss of GPI modification can lead to aberrant trafficking
and degradation, whereas in others, loss of GPI modification
results in proteins that are secreted (Campana et al., 2007;
Maeda and Kinoshita, 2011; Mayor and Riezman, 2004). To
distinguish between the two possibilities, we probed for the
presence of FLAG::EFN-4ΔGPI in the culture medium of
HEK293T cells expressing FLAG::EFN-4ΔGPI by performing
immunoprecipitation on the culture medium with anti-EFN-4
antibodies. Western blot analyses of the immunoprecipitates
using an anti-FLAG antibody revealed the presence of FLAG::
EFN-4ΔGPI in the medium, demonstrating that EFN-4ΔGPI can be
secreted extracellularly. These results, combined with the genetic
analyses, support the notion that EFN-4 can function as a soluble
diffusible factor to mediate SDQL axon guidance.
SUP-17, the ADAM10 ortholog, might function in EFN-4-
mediated axon guidance
The robust rescue of efn-4-dependent SDQL axon guidance defects
with remote expression of full-length EFN-4 suggests that GPI-
linked EFN-4 is released from the cell surface. In vertebrates, GPI-
linked ephrins can be released from the cell surface in a regulated
fashion by ADAM10- and ADAM12-dependent proteolytic
cleavage (Hattori et al., 2000; Janes et al., 2005). As a first
approach to determine whether an ADAM regulates EFN-4
proteolytic processing, we examined genetic mutants of sup-17,
which encodes the C. elegans ADAM10 ortholog (Wen et al.,
1997), for SDQL migration defects. Although loss of sup-17 results
in arrested embryonic development, sup-17 exhibits maternal
activity that partially rescues embryonic lethality of sup-17 null
alleles (Tax et al., 1997). We examined viable, maternally rescued
sup-17 null and hypomorphic animals and identified modest but
significant levels of SDQL axon pathfinding defects (Fig. 6),
indicating an axon guidance role for SUP-17.
In addition to ephrins, ADAM10 can proteolytically cleave
multiple different substrates, including ligands for the epidermal
growth factor receptor, adhesion molecules and Notch receptors
(Hartmann et al., 2002; Pruessmeyer and Ludwig, 2009; Sahin
et al., 2004). Previous genetic analyses of sup-17 support a role
for SUP-17 in processing LIN-12/Notch in C. elegans (Jarriault
and Greenwald, 2005; Tax et al., 1997; Wen et al., 1997). Thus,
the SDQL neuron defects observed in sup-17 animals might
result from defective processing of one or more SUP-17
substrates. To ascertain whether defective EFN-4 processing
contributes to this sup-17 SDQL cell migration defect, we tested
the ability for EFN-4ΔGPI to rescue sup-17 SDQL defects
(Fig. 6). Indeed, SDQL-specific expression of EFN-4ΔGPI but
not full-length EFN-4 rescued abnormal SDQL defects in sup-17
hypomorphic animals. Similarly, EFN-4ΔGPI but not full-length
EFN-4 expressed in the more distant RID neuron rescues SDQL
defects in sup-17 null animals. Surprisingly, we did not observe
rescue with SDQL expression of EFN-4ΔGPI in sup-17 null
animals as we did in the hypomorphic animals, despite the fact
that the EFN-4ΔGPI transgenes are common in both strains. The
reason for this is not clear, but the positive rescue we observed
reveals the ability for a putative soluble form of EFN-4 to bypass
SUP-17 function, consistent with the notion that SUP-17
functions in the processing of EFN-4. Because SDQL defects
in sup-17 null animals are less penetrant than in efn-4 null
animals, there are likely to be additional mechanisms underlying
EFN-4 processing, Moreover, the modest rescue by RID neuron
expression of EFN-4ΔGPI in sup-17 null animals suggests that
SUP-17 probably also promotes SDQL axon guidance through
EFN-4-independent pathways.
DISCUSSION
We report a novel role for ephrin EFN-4 in C. elegans axon
guidance. Our data suggest that EFN-4 acts as a soluble factor to
direct axon pathfinding via LAD-2, which probably functions as a
non-canonical receptor for EFN-4.
EFN-4 can act as a long-range axon guidance factor
Ephrins, both GPI-linked and transmembrane forms, typically
function as short-range cues to mediate cell repulsion in a juxtacrine
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Fig. 6. SUP-17 might function in EFN-4 processing. Quantitation of SDQL
defects in sup-17(n316) and sup-17(n1306) mutant backgrounds expressing
EFN-4ΔGPI or full-length EFN-4. We examined two independent transgenic
lines to analyze the effects of expression of each EFN-4 form in specific tissues
on SDQL migration. Error bars indicate standard error of proportion of three
sample sets, where n=100 animals for each set. **P<0.01; *P<0.05; n.s., not
significant.
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fashion. After forming trans interactions with cognate Eph
receptors, bound ephrins undergo regulated proteolytic cleavage
by ADAMs. This cleavage of ephrin severs the ephrin-Eph-
mediated cell-cell contact, thus resulting in cell repulsion (Hattori
et al., 2000; Janes et al., 2005).
Our study reveals that GPI-linked EFN-4 also functions in axon
guidance. But our data are consistent with EFN-4 acting as a soluble
diffusible factor. Indeed, provision of EFN-4ΔGPI in efn-4 mutant
animals, even in tissues distant from SDQL, is sufficient to rescue
SDQL cell defects, demonstrating that membrane association is not
required for EFN-4 function and that EFN-4 probably functions
as a soluble diffusible factor. In support of this hypothesis, we
demonstrate that EFN-4ΔGPI expressed in cultured HEK293 cells
can be secreted extracellularly.
Interestingly, soluble forms of mammalian GPI-linked ephrins
were recently found to be produced by glioblastoma multiforme
tumor cells when cultured ex vivo. In these studies, soluble forms
of ephrin A1 were released from these cells in a matrix
metalloprotease-dependent manner and are independent of cell-
cell contact. Moreover, when cultured cells, including embryonic
neurons, were exposed to soluble ephrin A1-conditioned medium,
diverse physiological changes were observed, including growth
cone collapse and attenuated cell migration (Beauchamp et al., 2012;
Wykosky et al., 2008). These studies, combined with our results,
reveal that conserved ephrin-mediated processes probably include
the use of endogenous soluble ephrins acting as diffusible factors.
These findings raise additional questions. How is soluble EFN-4
distributed? Do other EFN-4-mediated processes, such as male tail
and epidermal morphogenesis, also utilize soluble EFN-4? How is
GPI-linked EFN-4 released from the plasma membrane?
The ability for EFN-4ΔGPI, but not full-length EFN-4, to
rescue SDQL defects in sup-17 mutant animals suggests that the
SUP-17 ADAM protease functions in EFN-4 processing to free
EFN-4 from the plasma membrane. However, the less-penetrant
SDQL axon defect in sup-17 versus efn-4 null animals suggests
that SUP-17 is not the only protein to process EFN-4. Likewise,
the modest or lack of SDQL rescue in sup-17 null animals with
EFN-4ΔGPI suggests that the axon guidance defects in these
animals might be due to abnormal processing of additional sup-17
substrates besides EFN-4. Perhaps, these other substrates function
together with EFN-4, thus accounting for the poorer rescue of
SDQL defects in sup-17 null compared with the sup-17
hypomorphic background.
EFN-4: guidance cue or permissive factor?
The ability for EFN-4 expression in multiple tissues to rescue SDQL
axon pathfinding in efn-4 null animals indicates that EFN-4 can
function both cell autonomously and non-cell autonomously. Of the
tissues tested, EFN-4 expression in hyp7 cells produces the weakest
rescue (Fig. 4B), a surprising result considering that SDQL neurons
are in contact with hyp7 neurons throughout axon navigation. It is
not clear what the underlying reason is but we attribute this to
probable low EFN-4 expression in the dpy-7 promoter-driven
transgenic lines. In our experience, animals are sensitive to the
apparent toxicity of transgenes that utilize the dpy-7 promoter to
drive gene expression (L.C., unpublished results); as such, low sub-
lethal concentrations of the Pdpy-7::efn-4 construct were used to
generate transgenic efn-4 animal expressing efn-4 in hyp7 neurons
(see the Materials and Methods).
Does EFN-4 function as a repulsive or attractive guidance cue? In
addition to strong EFN-4 expression in the head and tail neurons,
robust EFN-4 expression is seen in the ventral nerve cord
(Chin-Sang et al., 2002; Fig. S1). On the basis of this expression
pattern and the dorsal-ward extension of the wild-type SDQL axon
to the dorsal sublateral cord, onewould predict that EFN-4 functions
as a repulsive cue. Supporting this notion, ventral EFN-4 expression
in the touch receptor mechanosensory neurons rescues SDQL
defects in efn-4 animals. If EFN-4 does indeed function as a
repulsive cue, one would predict that dorsal EFN-4 expression
would enhance SDQL axon guidance defects in efn-4 animals.
Contrary to this prediction, dorsal EFN-4 expression in the RID
neuron does not enhance efn-4 SDQL defects but instead, rescues it,
suggesting that EFN-4 acts as an attractive cue. Consistent with
EFN-4 functioning as an attractive cue, we observed a modest but
statistically significant SDQL axon defect with ventral EFN-4
expression in wild-type animals.
Axon navigation is a complex process that relies on the ability for
a neuron to integrate, interpret and respond to the signals of multiple
cues encountered during its navigation. For example, whether a
neuron responds to UNC-6 netrin as a repulsive or positive cue
depends not only on the netrin receptors present on the growth cone,
but also the presence of other guidance cues and extrinsic factors,
including UNC-129 that can influence the sensitivity of the UNC-6
receptors or mask the UNC-6 signal (Kim et al., 1999; MacNeil
et al., 2009). Thus the response of SDQL to ectopic EFN-4 might be
influenced by the strength and the temporal activity of the promoters
used to drive EFN-4 expression. An alternative explanation for the
SDQL rescue with both dorsal and ventral EFN-4 expression is that
EFN-4 functions as a permissive factor, rather than a guidance cue.
Supporting this possibility is the robust rescue of SDQL defects in
efn-4 animals with EFN-4 expression in multiple tissues that are
adjacent or distant to SDQL.
LAD-2 as a non-canonical ephrin receptor
Our genetic analysis reveals that VAB-1 functions in axon guidance
of lad-2-expressing neurons. However, the higher penetrance of
SDQL axon defects in efn-4 null animals compared with vab-1 null
animals indicates that EFN-4 can mediate axon guidance
independent of VAB-1. This finding is not surprising based on
the previous discovery that EFN-4 has VAB-1-independent roles in
epidermal morphogenesis and axon branching (Chin-Sang et al.,
2002; Schwieterman et al., 2016). Our study identifies LAD-2 as a
likely receptor for EFN-4 in axon guidance. Consistent with EFN-4
and LAD-2 having a ligand-receptor relationship, efn-4 and lad-2
both function in the same genetic pathway and EFN-4 can
biochemically interact with LAD-2.
The mammalian L1CAMs, L1 and CHL1, were recently shown
to function in ephrin-Eph-mediated retinal ganglion and
thalamocortical axon pathfinding (Dai et al., 2012; Demyanenko
et al., 2011b). These studies demonstrate that L1 and CHL1
biochemically interact with the corresponding Eph receptors, which
can regulate the phosphorylation state of L1 to modulate axon
guidance. Thus, Eph receptors are required for mammalian
L1CAMs to mediate pathfinding of these axons. This mechanism
might also be conserved in C. elegans because our genetic analysis
reveals that vab-1 functions in the same pathway as lad-2. However,
the weaker penetrance of axon defects in vab-1 versus efn-4 and
lad-2 null animals suggest that LAD-2 and EFN-4 can also function
independently of VAB-1. It is unclear whether this VAB-1-
independent LAD-2 function is also conserved with mammalian
L1CAMs. Given that both LAD-2 and mammalian L1CAMs are
conserved semaphorin co-receptors (Castellani et al., 2000, 2004;
Demyanenko et al., 2011a; Falk et al., 2005; Wang et al., 2008), we
surmise that this is likely.
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How do EFN-4 and LAD-2 mediate axon guidance? Our data
support a role for EFN-4 as a soluble diffusible factor that functions
in a separate pathway from MAB-20 and PLX-2. On the basis of
these findings, we propose three simple models for how EFN-4
facilitates LAD-2-mediated axon guidance. The first model
postulates that LAD-2 acts as a receptor for EFN-4, which acts as
a guidance cue that provides an additional signal to MAB-20 to
direct SDQL axon guidance. The second model proposes that EFN-
4 functions as a permissive factor and that EFN-4 binding to LAD-2
potentiates the ability for LAD-2 to more efficiently transmit a
MAB-20 guidance signal or additional as-yet-unidentified guidance
cues, perhaps by influencing LAD-2 conformation. Alternatively,
soluble EFN-4 could act as a permissive factor by being deposited
along the extracellular matrix and facilitating adhesion of the
migrating SDQL axon via LAD-2. These latter two models, which
might not be mutually exclusive, require that soluble EFN-4 has a
relatively high diffusion rate and/or that low extracellular EFN-4
concentration is sufficient. Further analysis will have to be
performed to test the validity of these models.
How does LAD-2 function as a receptor, particularly because
LAD-2 does not harbor obvious catalytic domains or conserved
motifs in the cytoplasmic tail that could link LAD-2 to a signal
transduction pathway? As LAD-2 functions to bridge MAB-20 to
PLX-2 (Wang et al., 2008), LAD-2 might similarly act as a co-
receptor to link EFN-4 to an as-yet-unidentified receptor. An
alternative possibility is that LAD-2 can, in fact, function as a
receptor to mediate EFN-4 signals intracellularly by as-yet-
unknown mechanisms. Additional studies will have to be
performed to distinguish these two possibilities.
MATERIALS AND METHODS
Strains
C. elegans strains, provided by the Caenorhabditis Genetics Center, were
grown on nematode growth medium (NGM) plates at 21°C. N2 Bristol
served as the wild-type strain (Brenner, 1974). The alleles used in this study
are listed by linkage groups as follows: LGI: sup-17(n316), sup-17(n1306)
(Tax et al., 1997), mab-20(ev574); LGII: vab-1(dx31) (George et al., 1998),
plx-2(ev773); LGIV: efn-4(bx80) (Chin-Sang et al., 2002), lad-2(tm3056)
(Wang et al., 2008).
C. elegans expression vectors and generation of transgenic
animals
Transgenic animals were generated according to standard procedures (Mello
et al., 1991). We injected efn-4(bx80), sup-17(n316) and sup-17(n1306)
unc-29(e1072)/hT2[qIs48] with the following efn-4 expression constructs
with 50 ng/µl Plad-2::gfp as a co-injection marker that also allows
visualization of SDQL. The concentration of the efn-4 expression
constructs used to generate transgenic animals is listed below.
Plad-2::gfp (pLC373): 9 kb of lad-2 sequences upstream of the start
codon was PCR-amplified and subcloned into pBSII KS- together with GFP
coding sequence and lad-2 3′UTR. Injected as a co-injection marker at
50 ng/µl. Pefn-4::efn-4 (pLC667): efn-4 genomic DNA was amplified by
PCR and cloned between the NotI and EcoRV sites of pBS II KS- (Chin-
Sang et al., 2002). Injected at 20 ng/µl. Plad-2::efn-4 (pLC670): subcloned
into pBSII KS-, 9 kb of lad-2 upstream sequence was subcloned together
with efn-4 genomic sequence that was amplified from pLC667 at the start
codon (Wang et al., 2008). Injected at 20 ng/µl. Pdpy-7::efn-4 (pLC678):
promoter sequence of pLC667 was replaced with PCR-amplified dpy-7
promoter fragment (Gilleard et al., 1997). Injected at 2.5 ng/µl. Pmyo-3::
efn-4 (pLC681): promoter sequence of pLC667 was replaced with PCR-
amplified myo-3 promoter fragment (Okkema et al., 1993). Injected at
15 ng/µl. Pmir-48::efn-4 (pLC688): promoter sequence of pLC667 was
replaced with PCR-amplified mir-48 promoter fragment (Li et al., 2005).
Injected at 20 ng/µl. Pmec-7::efn-4 (pLC692): Promoter sequence of
pLC667 was replaced with PCR-amplified mec-7 promoter fragment
(Kim et al., 1999). Injected at 20 ng/µl. Plad-2::EFN-4ΔGPI (pLC686): the
efn-4 sequence of pLC670 was truncated following amino acid 327, thereby
deleting the GPI signal sequence. A stop codon was inserted after the amino
acid 327. Injected at 20 ng/µl. Pmir-48::EFN-4ΔGPI (pLC710): promoter
sequence of pLC686 was replaced with mir-48 promoter fragment. Injected
at 20 ng/µl. Pmec-7::EFN-4ΔGPI (pLC709): Promoter sequence of pLC686
was replaced with mec-7 promoter fragment. Injected at 20 ng/µl.
Phenotypic analysis of SMD, PLN, SDQR and SDQL axons
Young adult animals were mounted on 2% agarose pads, paralyzed in M9
buffer containing 10 mM levamisole and examined using an Axioplan 2
microscope (Carl Zeiss). The SDQL axon was scored as having a migration
defect if it migrated ventrally at the second dorsal turn. This phenotype is
distinct from the bipolar phenotype, which was scored as such if the SDQL
neuron extended two axons. Three sample sets were analyzed for each
genetic strain, where n=100 for each sample set. Statistical analysis was
performed using ANOVA followed by post hoc pairwise Student’s t-test
with Bonferroni correction. Confocal micrographs of SDQL axons in
different genetic backgrounds in Fig. 1 were taken using the 40× objective of
an Olympus Fluoview FV1000 upright confocal microscope. Images were
collected as stacks along the z-axis. Shown are maximum intensity
projections obtained using the Fluoview software.
To examine SDQL phenotypes in the sup-17(n1306) null background, we
performed all manipulations in the sup-17(n1306) unc-29(e1072)/hT2
[qIs48] animals. We then examined viable homozygous sup-17(n1306) unc-
29(e1072) animals, which are uncoordinated because of the closely linked
unc-29 mutation and lack the green pharynx found in the Pmyo-2::GFP-
carrying hT2[qIs48] balancer chromosome. unc-29 encodes an
acetylcholine receptor subunit and does not have a reported role in axon
guidance (Fleming et al., 1997).
Immunofluorescence
Animals were fixed and stained for indirect immunofluorescence using the
freeze-crack methanol fixation method (Chen et al., 2001). EFN-4
polyclonal antibodies (Chin-Sang et al., 2002) were used at 1:200
dilution. Secondary antibodies (Alexa Fluor 488 and 568, Molecular
Probes) were used at 1:500 dilution.
Mammalian cell expression vectors
pCMV::LAD-2::HA (pLC669): lad-2 cDNA was PCR-amplified with a
primer-encoded HA tag and cloned into pCDNA3.1/Myc HisB between the
EcoRI and EcoRV sites. pCMV::FLAG::EFN-4 (pLC642): efn-4 cDNA
was cloned into 3xFLAG-CMV 7.1 between the EcoRI and EcoRV sites.
pCMV::FLAG::EFN-4ΔGPI (pLC 707): efn-4 cDNA was PCR-amplified
using primers that remove the last 29 amino acids of EFN-4 containing the
GPI modification sequence and cloned in 3xFLAG-CMV 7.1 between the
EcoRI and EcoRV sites. LAD-2ECD::AP (pLC714): lad-2 cDNA was
truncated following amino acid 1126 and cloned into vector pAPtag-2
(GenHunter) between the HinDIII and BglII sites.
Fc-MycHis (pMH180): Fc open reading frame was PCR-amplified from
plasmid pCXFc-KAL (Bulow et al., 2002) and subcloned into pSecTagA
(Life Technologies) between the HindIII and EcoRI sites. EFN-4ΔGPI-Fc-
MycHis (pMH874): EFN-4 cDNA was PCR-amplified with the following
primers so that the first 26 amino acids, which form the secretion signal, as
well as the last 22 amino acids, which constitute the GPI modification signal,
are not included. This PCR product was subcloned using Gibson Assembly
(New England BioLabs) into HindIII-linearized pMH180. Forward primer:
AGGCGCGCCGTACGAAGcttAGACGAGCACATTGTCTAC; reverse
primer: AAAATCCTTGGAATATTtAAGcttCGACAAAACTCACACA.
Cell culture and transfection
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Caisson Laboratories and Mediatech) supplemented with 10%
ultra-low IgG fetal bovine serum (Life Technologies), 1 mM L-glutamine
(Caisson Laboratories Inc.), and 1× penicillin-streptomycin (Caisson
Laboratories). HEK293T cells were transfected with LipofectAMINE 2000
Transfection Reagent (Life Technologies) and Opti-MEM Reduced Serum
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Medium (Life Technologies) according to the manufacturer’s protocol. Final
DNA concentrations were 10 ng/μl. Transfections were incubated at 37°C in
5% CO2 atmosphere for 40-48 h. Cells that were transfected for co-
immunoprecipitation assays were isolated and washed with PBS. For cells
that were transfected for BLI analysis, supernatants were harvested,
centrifuged to remove cellular debris, then used directly or concentrated
using a 10 kDa cut-off filter (Centricon). Protein production was confirmed
by either western blotting to detect Myc tags of the transfected ephrin-Fc
proteins, or by AP-turnover assay for LAD-2ECD::AP. For cells that were
transfected to assess secretion of EFN-4ΔGPI, the supernatants were
collected at 48 h and for three subsequent days, concentrated using Amicon
Ultra-15 filter devices (Millipore), and subjected to immunoprecipitation
with EFN-4 polyclonal antibodies (Chin-Sang et al., 2002).
Co-immunoprecipitation assays
200-500 µl of cell lysate was incubated with NETN buffer (20 mMTris-HCl,
pH 8, 100 mM NaCl, 1 mM EDTA and 0.5% NP-40) containing an anti-
FLAG M2 monoclonal antibody (Sigma-Aldrich, F1804; 1 μg) or anti-Myc
polyclonal antibody (Covance, 9E10; 1 μg) or anti-SAX-7 polyclonal
antibody (6991; Chen et al., 2001; 1 μg) at 4°C for 4 h followed by an
incubation with 20 µl protein A/G beads (Santa Cruz Biotechnology) for 2 h
orovernight. The beadswere thenwashed three timeswithNETN lysis buffer.
Western blot analysis and reagents
Cell lysates prepared in NETN buffer containing 1 mM NaF, 2.5 mM
β-glycerophosphate and a protease inhibitor cocktail (Life Technologies).
Protein concentrations were determined with the Bio-Rad protein assay
(Bio-Rad). Proteins in cell lysates were resolved by SDS-PAGE and
electrophoretically transferred to nitrocellulose membrane. Membranes
were processed as described in Wang et al. (2008). Primary antibodies used
included anti-FLAG M2 (Sigma-Aldrich, 16B12; 1:1000), anti-Myc
(Covance, 9E10;1:1000) and anti-HA (Covance, MMS-101P; 1:1000).
Biolayer interferometry (BLI)
Biolayer interferometry measurements were made on a FortéBio Octet-QK
instrument using anti-human IgG Fc capture (AHC) biosensors. Assays of
200 μl volumes were performed in 96-well microplates at 25°C. Biosensors
were conditioned for 3 min in Opti-MEM medium prior to loading. Ephrin-
Fc ligands or Fc controls were bound onto the AHC biosensors for 60 min
then a baseline was established in Opti-MEM for 15 min. Sensors were then
incubated in LAD-2ECD::AP tissue culture supernatant for 60 min (analyte
association phase), followed by incubation in Opti-MEM for 60 min
(dissociation phase).
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